Ilyang Pharmaceutical has agreed to export its homegrown drugs, Noltec (ilaprazole) and Supect (rodotinib) to a Turkish firm.
Ilaprazole is a new investigational proton pump inhibitor (PPI), and Supect is believed to be 30 times more effective than Glivec, a popular anti-leukemia medicine.
A company spokesman said Ilyang President Kim Dong-yeon and Abdi Ibrahim Chairman Nezih Barut signed...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.